Se-methylselenocysteine has been reported to promote mitochondrial biosynthesis in 14-month-old 3xTg-AD mice by increasing the expression levels of NRF1 and NRF2 (Xie et al., 2018). Here, NRF1 is linked to Alzheimer disease.